UBROGEPANT

UBROGEPANT was reported 6366 times

UBROGEPANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CERVICOGENIC HEADACHE 18 0.1324
1 PINEAL GLAND CYST 18 0.1286
2 HABITUAL ABORTION 13 0.1140
3 SINUPLASTY 3 0.0833
4 MIGRAINE WITHOUT AURA 22 0.0733
5 HEMIPLEGIC MIGRAINE 16 0.0472
6 IRON METABOLISM DISORDER 3 0.0252
7 OCCIPITAL NEURALGIA 11 0.0195
8 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 7 0.0164
9 PSEUDOSTROKE 5 0.0145
10 ILIOTIBIAL BAND SYNDROME 3 0.0133
11 OPHTHALMIC MIGRAINE 9 0.0129
12 MEDICATION OVERUSE HEADACHE 10 0.0117
13 MIGRAINE 921 0.0096
14 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 13 0.0096
15 INCREASED DOSE ADMINISTERED 3 0.0096
16 MAST CELL ACTIVATION SYNDROME 13 0.0093
17 EHLERS-DANLOS SYNDROME 4 0.0086
18 AURA 16 0.0086
19 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3 0.0085
20 PIGMENTARY MACULOPATHY 4 0.0083
21 VOCAL CORD DYSFUNCTION 4 0.0081
22 POLYCYSTIC OVARIAN SYNDROME 3 0.0078
23 NERVE BLOCK 4 0.0068
24 TENSION HEADACHE 29 0.0067
25 MIGRAINE WITH AURA 17 0.0063
26 CLUSTER HEADACHE 8 0.0058
27 PRODUCT ADMINISTRATION INTERRUPTED 45 0.0057
28 CERVICAL RADICULOPATHY 4 0.0056
29 AUTOSCOPY 3 0.0056
30 IDIOPATHIC INTRACRANIAL HYPERTENSION 12 0.0053
31 THERAPEUTIC PRODUCT EFFECT DELAYED 24 0.0053
32 SALPINGECTOMY 3 0.0052
33 NECK SURGERY 12 0.0052
34 INFUSION SITE DISCHARGE 9 0.0051
35 INFUSION SITE BRUISING 11 0.0051
36 SITTING DISABILITY 3 0.0049
37 ALLERGY TO CHEMICALS 6 0.0048
38 OBSTRUCTIVE SLEEP APNOEA SYNDROME 7 0.0048
39 SERUM SICKNESS-LIKE REACTION 3 0.0048
40 TONGUE PRURITUS 4 0.0046
41 THERAPEUTIC PRODUCT EFFECT VARIABLE 17 0.0044
42 CEREBROSPINAL FLUID LEAKAGE 8 0.0043
43 LUMBAR RADICULOPATHY 5 0.0043
44 LYMPH NODE PAIN 8 0.0043
45 MEDICAL PROCEDURE 7 0.0042
46 INTUSSUSCEPTION 4 0.0042
47 RECTAL PROLAPSE 5 0.0041
48 CEREBRAL ARTERY EMBOLISM 5 0.0041
49 CYCLIC VOMITING SYNDROME 3 0.0041
50 CERVICAL SPINAL STENOSIS 7 0.0041
51 THERAPEUTIC RESPONSE DELAYED 11 0.0039
52 BACTERIAL VAGINOSIS 6 0.0038
53 PROCEDURAL NAUSEA 3 0.0037
54 TONGUE ERYTHEMA 3 0.0036
55 GIANT CELL ARTERITIS 3 0.0036
56 POST-TRAUMATIC STRESS DISORDER 24 0.0036
57 BRAIN OPERATION 8 0.0035
58 LIP PRURITUS 3 0.0035
59 SURGICAL FAILURE 4 0.0035
60 ENDOCRINE OPHTHALMOPATHY 3 0.0035
61 IMPAIRED GASTRIC EMPTYING 47 0.0034
62 SINUS PAIN 8 0.0034
63 INTRUSIVE THOUGHTS 4 0.0034
64 TERMINAL INSOMNIA 6 0.0034
65 ELECTRIC SHOCK SENSATION 9 0.0032
66 THERAPEUTIC RESPONSE SHORTENED 106 0.0032
67 ARNOLD-CHIARI MALFORMATION 3 0.0031
68 ANIMAL SCRATCH 3 0.0031
69 GASTRECTOMY 3 0.0030
70 HYPERACUSIS 11 0.0030
71 POLYHYDRAMNIOS 3 0.0029
72 INFUSION SITE DISCOMFORT 3 0.0029
73 INFUSION SITE PRURITUS 9 0.0028
74 ALLERGY TO ANIMAL 3 0.0028
75 HYPERTONIC BLADDER 8 0.0028
76 INFUSION SITE MASS 3 0.0028
77 BRAIN FOG 43 0.0027
78 UTERINE SPASM 5 0.0027
79 ESSENTIAL TREMOR 3 0.0027
80 MULTIPLE ALLERGIES 21 0.0027
81 CHEMICAL BURN 3 0.0026
82 JC POLYOMAVIRUS TEST POSITIVE 3 0.0026
83 SINUS OPERATION 6 0.0025
84 SPINAL OPERATION 31 0.0025
85 MAGNETIC RESONANCE IMAGING ABNORMAL 3 0.0025
86 CONCUSSION 19 0.0025
87 INFUSION SITE WARMTH 3 0.0024
88 LIVEDO RETICULARIS 5 0.0024
89 DRUG EFFECT LESS THAN EXPECTED 35 0.0024
90 FOOD ALLERGY 18 0.0023
91 GESTATIONAL HYPERTENSION 3 0.0023
92 SERUM FERRITIN DECREASED 4 0.0023
93 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
94 SKIN HYPOPIGMENTATION 4 0.0023
95 INFUSION SITE RASH 3 0.0022
96 NASAL DISCHARGE DISCOLOURATION 3 0.0022
97 ATTENTION DEFICIT HYPERACTIVITY DISORDER 9 0.0021
98 GLUTEN SENSITIVITY 3 0.0021
99 FACE INJURY 8 0.0021
100 SHOULDER OPERATION 9 0.0021
101 THYROID MASS 8 0.0021
102 AUTONOMIC NERVOUS SYSTEM IMBALANCE 6 0.0021
103 GENERALISED ANXIETY DISORDER 3 0.0020
104 COMPLEX REGIONAL PAIN SYNDROME 3 0.0020
105 FEELING DRUNK 15 0.0020
106 DEVICE INFUSION ISSUE 5 0.0020
107 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 143 0.0020
108 MENTAL FATIGUE 3 0.0020
109 CRANIOCEREBRAL INJURY 6 0.0020
110 HYSTERECTOMY 17 0.0020
111 POLYCYSTIC OVARIES 3 0.0019
112 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
113 MEDICAL DEVICE IMPLANTATION 3 0.0019
114 SLEEP DEFICIT 4 0.0019
115 NASAL ULCER 3 0.0019
116 LIMB OPERATION 9 0.0019
117 CYSTITIS INTERSTITIAL 3 0.0019
118 SHOULDER ARTHROPLASTY 5 0.0019
119 SNORING 7 0.0018
120 DENTAL IMPLANTATION 3 0.0018
121 INFUSION SITE HAEMORRHAGE 6 0.0018
122 FOOT OPERATION 9 0.0018
123 LIVE BIRTH 15 0.0018
124 INTERMENSTRUAL BLEEDING 10 0.0018
125 SEIZURE LIKE PHENOMENA 3 0.0018
126 PRE-EXISTING CONDITION IMPROVED 11 0.0018
127 INFUSION SITE SWELLING 11 0.0017
128 CERVICAL VERTEBRAL FRACTURE 6 0.0017
129 BLOOD CHLORIDE INCREASED 3 0.0017
130 EYELID DISORDER 4 0.0017
131 SPINAL FUSION SURGERY 7 0.0017
132 MASTECTOMY 3 0.0017
133 INSURANCE ISSUE 26 0.0017
134 UPPER-AIRWAY COUGH SYNDROME 14 0.0017
135 APPENDICECTOMY 6 0.0017
136 ENDOMETRIOSIS 8 0.0017
137 JOINT ARTHROPLASTY 3 0.0017
138 DISABILITY 33 0.0017
139 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
140 SEASONAL ALLERGY 23 0.0016
141 CEREBRAL DISORDER 12 0.0016
142 PHOTOPHOBIA 30 0.0016
143 PERIORBITAL SWELLING 9 0.0016
144 HYPOREFLEXIA 3 0.0016
145 MOTION SICKNESS 3 0.0016
146 INFUSION SITE ERYTHEMA 13 0.0015
147 INCORRECT DISPOSAL OF PRODUCT 5 0.0015
148 JOINT NOISE 3 0.0015
149 PARAESTHESIA ORAL 22 0.0015
150 THERAPEUTIC PRODUCT EFFECT DECREASED 68 0.0015
151 SURGERY 89 0.0015
152 ANIMAL BITE 4 0.0015
153 DERMATITIS CONTACT 17 0.0015
154 PRODUCT USE COMPLAINT 23 0.0015
155 HYPERPARATHYROIDISM 3 0.0015
156 CHEST INJURY 3 0.0014
157 KNEE OPERATION 14 0.0014
158 HANGOVER 5 0.0014
159 FACIAL PARALYSIS 12 0.0014
160 IMPAIRED QUALITY OF LIFE 20 0.0014
161 JAW FRACTURE 3 0.0014
162 INJECTION SITE INDENTATION 3 0.0014
163 FEEDING DISORDER 27 0.0013
164 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
165 VASCULAR DEVICE INFECTION 6 0.0013
166 PARANASAL SINUS DISCOMFORT 5 0.0013
167 PARANASAL SINUS HYPERSECRETION 5 0.0013
168 ORAL SURGERY 3 0.0013
169 THERAPEUTIC RESPONSE DECREASED 76 0.0013
170 INTRACRANIAL ANEURYSM 5 0.0012
171 HEAD DISCOMFORT 22 0.0012
172 COLECTOMY 7 0.0012
173 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
174 GALLBLADDER OPERATION 5 0.0012
175 MAJOR DEPRESSION 9 0.0012
176 HORMONE LEVEL ABNORMAL 6 0.0012
177 COELIAC DISEASE 12 0.0012
178 PANCREATIC DISORDER 6 0.0012
179 APPETITE DISORDER 8 0.0012
180 ILLNESS 124 0.0012
181 LYME DISEASE 4 0.0012
182 BRAIN NEOPLASM 11 0.0012
183 PAROSMIA 9 0.0012
184 INTENTIONAL DOSE OMISSION 34 0.0012
185 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
186 ENDODONTIC PROCEDURE 3 0.0012
187 ABDOMINAL INFECTION 3 0.0012
188 ABNORMAL UTERINE BLEEDING 3 0.0012
189 MENOPAUSE 3 0.0012
190 LYMPHOEDEMA 8 0.0012
191 CATHETER SITE PAIN 3 0.0012
192 SENSITIVITY TO WEATHER CHANGE 6 0.0011
193 DEVICE DIFFICULT TO USE 75 0.0011
194 AREFLEXIA 3 0.0011
195 BRUXISM 6 0.0011
196 OROPHARYNGEAL DISCOMFORT 10 0.0011
197 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 53 0.0011
198 LIP BLISTER 3 0.0011
199 CLUMSINESS 3 0.0011
200 RHINALGIA 3 0.0011
201 EYE OPERATION 5 0.0011
202 BLINDNESS TRANSIENT 8 0.0011
203 PRODUCT DISTRIBUTION ISSUE 10 0.0011
204 HYPOAESTHESIA ORAL 16 0.0011
205 IMPAIRED DRIVING ABILITY 12 0.0011
206 SLEEP APNOEA SYNDROME 20 0.0010
207 THROAT IRRITATION 47 0.0010
208 ACCIDENTAL UNDERDOSE 15 0.0010
209 OESOPHAGEAL DISORDER 4 0.0010
210 VERTIGO 63 0.0010
211 FAECES HARD 4 0.0010
212 STRABISMUS 3 0.0010
213 VULVOVAGINAL MYCOTIC INFECTION 4 0.0010
214 OBSTRUCTION 4 0.0010
215 NOCTURIA 12 0.0010
216 VITAMIN B12 DEFICIENCY 4 0.0010
217 FEAR OF INJECTION 7 0.0010
218 INJECTION SITE HYPERSENSITIVITY 3 0.0010
219 PARTIAL SEIZURES 5 0.0010
220 ARTHROPOD BITE 7 0.0009
221 INJECTION SITE URTICARIA 23 0.0009
222 INFUSION SITE PAIN 12 0.0009
223 HIP SURGERY 5 0.0009
224 FACET JOINT SYNDROME 3 0.0009
225 HEADACHE 575 0.0009
226 DEAFNESS NEUROSENSORY 3 0.0009
227 GASTROINTESTINAL PAIN 10 0.0009
228 OTITIS MEDIA 3 0.0009
229 LIGAMENT RUPTURE 4 0.0009
230 FIBROMYALGIA 22 0.0009
231 COVID-19 158 0.0009
232 INTRACRANIAL PRESSURE INCREASED 5 0.0009
233 APHASIA 27 0.0009
234 SKIN INFECTION 10 0.0009
235 BRONCHIECTASIS 6 0.0009
236 HEAVY MENSTRUAL BLEEDING 8 0.0009
237 SINUS CONGESTION 12 0.0009
238 EYE PAIN 50 0.0009
239 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 15 0.0009
240 NASAL DISCOMFORT 7 0.0009
241 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
242 HAEMOGLOBIN INCREASED 4 0.0009
243 NEUROLOGICAL SYMPTOM 5 0.0009
244 TEMPERATURE INTOLERANCE 9 0.0009
245 MUSCULOSKELETAL DISCOMFORT 15 0.0009
246 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
247 THERAPY INTERRUPTED 62 0.0009
248 NERVE COMPRESSION 8 0.0009
249 MIDDLE INSOMNIA 16 0.0009
250 ROTATOR CUFF SYNDROME 11 0.0009
251 UMBILICAL HERNIA 4 0.0009
252 HEAD INJURY 27 0.0009
253 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
254 THROAT TIGHTNESS 23 0.0008
255 PRODUCT SUPPLY ISSUE 6 0.0008
256 EAR INFECTION 22 0.0008
257 MONOCYTE COUNT INCREASED 3 0.0008
258 SOMNOLENCE 166 0.0008
259 NECK PAIN 46 0.0008
260 SEIZURE 95 0.0008
261 UPPER RESPIRATORY TRACT INFECTION 38 0.0008
262 AUTOIMMUNE DISORDER 8 0.0008
263 VITAMIN D DEFICIENCY 8 0.0008
264 FOOD INTOLERANCE 3 0.0008
265 VITAMIN D DECREASED 7 0.0008
266 PHARYNGEAL SWELLING 8 0.0008
267 PRODUCT DOSE OMISSION ISSUE 240 0.0008
268 PARADOXICAL DRUG REACTION 3 0.0008
269 VITREOUS FLOATERS 8 0.0008
270 ROAD TRAFFIC ACCIDENT 34 0.0008
271 PRODUCT TASTE ABNORMAL 11 0.0008
272 PAIN IN JAW 23 0.0008
273 DRUG INEFFECTIVE 1069 0.0008
274 THINKING ABNORMAL 15 0.0008
275 OCULAR DISCOMFORT 9 0.0008
276 BRAIN INJURY 8 0.0008
277 EYE INFECTION 9 0.0008
278 PROTEIN TOTAL DECREASED 3 0.0008
279 AUTOIMMUNE THYROIDITIS 3 0.0008
280 PRODUCT COMMUNICATION ISSUE 7 0.0008
281 PHOTOPSIA 5 0.0008
282 DYSLIPIDAEMIA 4 0.0008
283 EYELID PTOSIS 8 0.0008
284 FACIAL PAIN 7 0.0008
285 PETIT MAL EPILEPSY 4 0.0008
286 CLAVICLE FRACTURE 3 0.0008
287 NEOPLASM 9 0.0008
288 POST PROCEDURAL COMPLICATION 15 0.0008
289 INITIAL INSOMNIA 8 0.0008
290 ASTHMA 88 0.0008
291 PRODUCT DOSE OMISSION IN ERROR 22 0.0008
292 REHABILITATION THERAPY 3 0.0008
293 VARICOSE VEIN 4 0.0008
294 PALPITATIONS 90 0.0008
295 HIDRADENITIS 7 0.0008
296 NEPHROLITHIASIS 35 0.0008
297 SOMNAMBULISM 5 0.0008
298 INCREASED TENDENCY TO BRUISE 7 0.0008
299 SINUS DISORDER 15 0.0008
300 ADVERSE DRUG REACTION 68 0.0008
301 EXPOSURE VIA BREAST MILK 3 0.0008
302 IMPAIRED WORK ABILITY 16 0.0007
303 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
304 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
305 FOOD POISONING 4 0.0007
306 IRRITABLE BOWEL SYNDROME 16 0.0007
307 PRODUCT SIZE ISSUE 4 0.0007
308 DRUG DOSE OMISSION BY DEVICE 58 0.0007
309 PRODUCT LABEL ISSUE 5 0.0007
310 SKIN LACERATION 8 0.0007
311 CHEST DISCOMFORT 75 0.0007
312 NASAL CONGESTION 43 0.0007
313 INJECTION SITE WARMTH 15 0.0007
314 TENDON RUPTURE 9 0.0007
315 PERIPHERAL COLDNESS 10 0.0007
316 ASTHENOPIA 4 0.0007
317 SEDATION 19 0.0007
318 HEMIPLEGIA 6 0.0007
319 FORMICATION 5 0.0007
320 MATERNAL EXPOSURE DURING PREGNANCY 64 0.0007
321 HEART RATE ABNORMAL 4 0.0007
322 INJECTION SITE PRURITUS 48 0.0007
323 MALNUTRITION 8 0.0007
324 SELF-INJURIOUS IDEATION 3 0.0007
325 SNEEZING 16 0.0007
326 SENSATION OF FOREIGN BODY 6 0.0007
327 MUSCLE FATIGUE 3 0.0007
328 BLOOD PRESSURE ABNORMAL 14 0.0007
329 HEPATIC PAIN 3 0.0007
330 CONSTIPATION 153 0.0007
331 NEURALGIA 17 0.0007
332 SUICIDAL IDEATION 64 0.0007
333 NAUSEA 553 0.0007
334 PARALYSIS 10 0.0007
335 HORDEOLUM 3 0.0007
336 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
337 TASTE DISORDER 14 0.0007
338 SKIN WARM 4 0.0007
339 DIVERTICULUM INTESTINAL 3 0.0007
340 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 139 0.0007
341 DYSPHEMIA 3 0.0007
342 UTERINE LEIOMYOMA 5 0.0007
343 ONYCHOMYCOSIS 3 0.0007
344 COLD SWEAT 12 0.0007
345 POOR VENOUS ACCESS 7 0.0007
346 TINNITUS 31 0.0007
347 BLOOD IRON DECREASED 8 0.0007
348 PLEURISY 4 0.0007
349 BRAIN NEOPLASM MALIGNANT 3 0.0007
350 PULMONARY MASS 10 0.0007
351 IMMUNODEFICIENCY 10 0.0007
352 IRON DEFICIENCY 3 0.0007
353 PHOTOSENSITIVITY REACTION 11 0.0007
354 INJECTION SITE DISCOMFORT 7 0.0007
355 KNEE ARTHROPLASTY 14 0.0007
356 FEELING ABNORMAL 159 0.0007
357 SINUSITIS 68 0.0007
358 KIDNEY INFECTION 13 0.0007
359 EATING DISORDER 14 0.0007
360 HIP ARTHROPLASTY 10 0.0007
361 BOWEL MOVEMENT IRREGULARITY 5 0.0007
362 HEMIPARESIS 11 0.0006
363 FEELING COLD 18 0.0006
364 ANKLE FRACTURE 10 0.0006
365 EYE SWELLING 24 0.0006
366 APHTHOUS ULCER 5 0.0006
367 TOOTH EXTRACTION 8 0.0006
368 INFUSION SITE EXTRAVASATION 4 0.0006
369 THERAPY PARTIAL RESPONDER 10 0.0006
370 SUSPECTED SUICIDE 3 0.0006
371 SKIN ABRASION 3 0.0006
372 HYPOAESTHESIA 95 0.0006
373 THERAPEUTIC RESPONSE CHANGED 4 0.0006
374 FOREIGN BODY SENSATION IN EYES 4 0.0006
375 MYASTHENIA GRAVIS 5 0.0006
376 INCORRECT DOSE ADMINISTERED BY DEVICE 16 0.0006
377 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
378 BEDRIDDEN 8 0.0006
379 EYE IRRITATION 35 0.0006
380 MUSCLE TWITCHING 14 0.0006
381 LIGAMENT SPRAIN 6 0.0006
382 HEART RATE INCREASED 60 0.0006
383 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 109 0.0006
384 MENSTRUAL DISORDER 5 0.0006
385 PANIC ATTACK 22 0.0006
386 ELECTROLYTE IMBALANCE 7 0.0006
387 INJECTION SITE INFLAMMATION 3 0.0006
388 BREAST CANCER FEMALE 16 0.0006
389 ANAPHYLACTIC REACTION 33 0.0006
390 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
391 POSTOPERATIVE WOUND INFECTION 4 0.0006
392 ULCER HAEMORRHAGE 4 0.0006
393 EUPHORIC MOOD 6 0.0006
394 SCAR 10 0.0006
395 WRIST FRACTURE 7 0.0006
396 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
397 RIB FRACTURE 12 0.0006
398 CARDIAC OPERATION 5 0.0006
399 PARAESTHESIA 91 0.0006
400 MUSCLE STRAIN 5 0.0006
401 CARDIAC MURMUR 5 0.0006
402 LOSS OF CONSCIOUSNESS 74 0.0006
403 EYE DISCHARGE 6 0.0006
404 FEELING JITTERY 11 0.0006
405 MALABSORPTION 3 0.0006
406 EXTRASYSTOLES 4 0.0006
407 BLOOD CALCIUM INCREASED 5 0.0006
408 INJECTION SITE PAIN 174 0.0006
409 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
410 DIZZINESS 282 0.0006
411 LYMPHADENOPATHY 20 0.0006
412 OBESITY 9 0.0006
413 ORAL HERPES 11 0.0006
414 JOINT INJURY 12 0.0006
415 BRONCHOSPASM 8 0.0006
416 COMPRESSION FRACTURE 3 0.0006
417 INJECTION SITE DISCHARGE 3 0.0006
418 CHEILITIS 3 0.0006
419 PANIC REACTION 4 0.0006
420 GASTROENTERITIS VIRAL 10 0.0006
421 BIPOLAR DISORDER 6 0.0006
422 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
423 OPTIC NEURITIS 5 0.0005
424 NONSPECIFIC REACTION 3 0.0005
425 PRODUCT PHYSICAL ISSUE 11 0.0005
426 DEAFNESS UNILATERAL 3 0.0005
427 CHOKING SENSATION 3 0.0005
428 HIATUS HERNIA 7 0.0005
429 GAIT INABILITY 18 0.0005
430 PRODUCT STORAGE ERROR 47 0.0005
431 HEPATIC STEATOSIS 10 0.0005
432 SUNBURN 4 0.0005
433 MENTAL IMPAIRMENT 13 0.0005
434 PRODUCT LEAKAGE 3 0.0005
435 FLANK PAIN 5 0.0005
436 BLOOD POTASSIUM DECREASED 16 0.0005
437 VISION BLURRED 73 0.0005
438 SPINAL DISORDER 5 0.0005
439 BLOOD URINE PRESENT 10 0.0005
440 INJECTION SITE BRUISING 42 0.0005
441 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
442 FEELING HOT 32 0.0005
443 JOINT RANGE OF MOTION DECREASED 7 0.0005
444 DISSOCIATION 4 0.0005
445 INJECTION SITE RASH 16 0.0005
446 EXERCISE TOLERANCE DECREASED 3 0.0005
447 DRY EYE 26 0.0005
448 LIMB DISCOMFORT 16 0.0005
449 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
450 ANXIETY 147 0.0005
451 DIZZINESS POSTURAL 5 0.0005
452 SPEECH DISORDER 27 0.0005
453 EAR PAIN 10 0.0005
454 APNOEA 4 0.0005
455 CEREBROVASCULAR ACCIDENT 87 0.0005
456 GASTROINTESTINAL DISORDER 46 0.0005
457 BURNING SENSATION 36 0.0005
458 CHEST PAIN 95 0.0005
459 SWOLLEN TONGUE 16 0.0005
460 SPINAL PAIN 6 0.0005
461 SKIN FISSURES 10 0.0005
462 POOR QUALITY SLEEP 11 0.0005
463 VIRAL INFECTION 17 0.0005
464 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
465 INJECTION SITE SWELLING 39 0.0005
466 AFFECTIVE DISORDER 4 0.0005
467 DECREASED INTEREST 3 0.0005
468 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
469 SINUS HEADACHE 3 0.0005
470 EMBEDDED DEVICE 5 0.0005
471 RESPIRATORY TRACT CONGESTION 8 0.0005
472 GINGIVAL PAIN 4 0.0005
473 ACCIDENT 6 0.0005
474 SYMPTOM RECURRENCE 3 0.0005
475 FATIGUE 389 0.0005
476 BLINDNESS UNILATERAL 7 0.0005
477 STENT PLACEMENT 4 0.0005
478 JOINT STIFFNESS 13 0.0005
479 PELVIC PAIN 9 0.0005
480 FRUSTRATION TOLERANCE DECREASED 4 0.0005
481 TREMOR 82 0.0005
482 COGNITIVE DISORDER 23 0.0005
483 BACK DISORDER 8 0.0005
484 POST PROCEDURAL INFECTION 4 0.0005
485 MOTOR DYSFUNCTION 5 0.0005
486 PRURITUS 188 0.0005
487 HYPERSOMNIA 14 0.0005
488 MUSCLE SPASTICITY 6 0.0005
489 ABNORMAL FAECES 4 0.0005
490 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
491 MENSTRUATION IRREGULAR 13 0.0005
492 DYSPHAGIA 46 0.0005
493 SCOLIOSIS 3 0.0005
494 VENTRICULAR EXTRASYSTOLES 5 0.0005
495 MULTIPLE SCLEROSIS 23 0.0005
496 VOMITING 226 0.0005
497 DRY MOUTH 39 0.0005
498 DYSSTASIA 14 0.0005
499 LIMB INJURY 13 0.0005
500 WEIGHT FLUCTUATION 5 0.0005
501 SWELLING OF EYELID 3 0.0005
502 FOOT FRACTURE 9 0.0005
503 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
504 CANDIDA INFECTION 8 0.0005
505 MEMORY IMPAIRMENT 65 0.0005
506 ABNORMAL DREAMS 13 0.0005
507 PROCEDURAL PAIN 13 0.0005
508 HEREDITARY ANGIOEDEMA 5 0.0005
509 INSOMNIA 124 0.0005
510 INJECTION SITE REACTION 32 0.0005
511 CARDIAC FLUTTER 3 0.0005
512 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
513 PHARYNGITIS STREPTOCOCCAL 5 0.0005
514 HERPES SIMPLEX 3 0.0005
515 ABDOMINAL DISTENSION 48 0.0005
516 OESOPHAGITIS 5 0.0005
517 ABDOMINAL PAIN UPPER 94 0.0005
518 EYE DISORDER 15 0.0005
519 PAIN 280 0.0005
520 SPINAL OSTEOARTHRITIS 4 0.0005
521 ANKYLOSING SPONDYLITIS 6 0.0005
522 TOOTH INFECTION 6 0.0005
523 TOOTH FRACTURE 5 0.0005
524 DYSMENORRHOEA 6 0.0005
525 PRESYNCOPE 11 0.0005
526 DENTAL CARIES 5 0.0005
527 LETHARGY 26 0.0005
528 FOOT DEFORMITY 5 0.0005
529 BLOOD CHOLESTEROL INCREASED 21 0.0005
530 FUNGAL INFECTION 15 0.0004
531 UNEVALUABLE EVENT 34 0.0004
532 SPINAL FRACTURE 9 0.0004
533 FOREIGN BODY IN REPRODUCTIVE TRACT 4 0.0004
534 QUALITY OF LIFE DECREASED 6 0.0004
535 ABDOMINAL DISCOMFORT 75 0.0004
536 MUSCLE SPASMS 82 0.0004
537 PAIN OF SKIN 12 0.0004
538 PRODUCT ADMINISTRATION ERROR 9 0.0004
539 DYSPHONIA 26 0.0004
540 BONE PAIN 26 0.0004
541 BLINDNESS 18 0.0004
542 URINARY TRACT INFECTION 75 0.0004
543 BALANCE DISORDER 38 0.0004
544 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
545 EXOSTOSIS 4 0.0004
546 ECCHYMOSIS 3 0.0004
547 PNEUMONIA BACTERIAL 4 0.0004
548 RESPIRATION ABNORMAL 3 0.0004
549 DROOLING 3 0.0004
550 IRON DEFICIENCY ANAEMIA 4 0.0004
551 RHINORRHOEA 28 0.0004
552 INJECTION SITE MASS 16 0.0004
553 ORAL DISCOMFORT 6 0.0004
554 HYPERTRANSAMINASAEMIA 3 0.0004
555 APHONIA 6 0.0004
556 HYPERTENSION 91 0.0004
557 MASS 6 0.0004
558 CARPAL TUNNEL SYNDROME 6 0.0004
559 DEFAECATION URGENCY 3 0.0004
560 ACCIDENTAL EXPOSURE TO PRODUCT 44 0.0004
561 DISCOMFORT 26 0.0004
562 BLOOD SODIUM DECREASED 8 0.0004
563 DIPLOPIA 11 0.0004
564 THERMAL BURN 3 0.0004
565 RESPIRATORY TRACT INFECTION 11 0.0004
566 PRODUCT PACKAGING ISSUE 4 0.0004
567 MUSCULOSKELETAL DISORDER 8 0.0004
568 CHOLECYSTITIS 5 0.0004
569 EYE INFLAMMATION 4 0.0004
570 MACULAR DEGENERATION 5 0.0004
571 SKIN CANCER 9 0.0004
572 URTICARIA 70 0.0004
573 DYSPEPSIA 41 0.0004
574 GLAUCOMA 8 0.0004
575 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
576 VISUAL IMPAIRMENT 51 0.0004
577 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
578 OROPHARYNGEAL PAIN 38 0.0004
579 CHOKING 8 0.0004
580 DISTURBANCE IN ATTENTION 22 0.0004
581 ARTHRITIS 32 0.0004
582 PSYCHIATRIC SYMPTOM 3 0.0004
583 SMALL INTESTINAL OBSTRUCTION 5 0.0004
584 WHEEZING 24 0.0004
585 DRUG INTOLERANCE 39 0.0004
586 CATARACT 24 0.0004
587 CYST 5 0.0004
588 ECZEMA 21 0.0004
589 THERAPY NON-RESPONDER 18 0.0004
590 INJECTION SITE DISCOLOURATION 5 0.0004
591 SALIVARY HYPERSECRETION 4 0.0004
592 PREGNANCY 8 0.0004
593 BLOOD PRESSURE INCREASED 61 0.0004
594 DEPRESSED MOOD 21 0.0004
595 SLEEP DISORDER 28 0.0004
596 ABDOMINAL PAIN LOWER 10 0.0004
597 PRODUCT AVAILABILITY ISSUE 9 0.0004
598 BRONCHITIS 29 0.0004
599 THIRST 7 0.0004
600 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
601 INTERCEPTED PRODUCT ADMINISTRATION ERROR 3 0.0004
602 INTRAOCULAR PRESSURE INCREASED 5 0.0004
603 EAR DISCOMFORT 4 0.0004
604 THYROID DISORDER 6 0.0004
605 INJECTION SITE HAEMORRHAGE 31 0.0004
606 ALOPECIA 76 0.0004
607 INJECTION SITE ERYTHEMA 48 0.0004
608 PELVIC FRACTURE 3 0.0004
609 FLUSHING 39 0.0004
610 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
611 HYPERHIDROSIS 49 0.0004
612 GASTRITIS 10 0.0004
613 SCRATCH 4 0.0004
614 FURUNCLE 3 0.0004
615 RENAL PAIN 4 0.0004
616 CONJUNCTIVITIS 7 0.0004
617 ADVERSE REACTION 5 0.0004
618 SCIATICA 6 0.0004
619 NIGHTMARE 13 0.0004
620 BACTERIAL INFECTION 7 0.0004
621 BLOOD DISORDER 3 0.0004
622 DEPRESSION 85 0.0004
623 LIVER FUNCTION TEST INCREASED 8 0.0004
624 RHINITIS 3 0.0004
625 DYSARTHRIA 14 0.0004
626 COUGH 104 0.0004
627 MUSCLE TIGHTNESS 6 0.0004
628 HEART RATE DECREASED 13 0.0004
629 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
630 DEHYDRATION 49 0.0004
631 PULMONARY THROMBOSIS 4 0.0004
632 MOOD ALTERED 10 0.0004
633 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
634 ESCHERICHIA INFECTION 3 0.0004
635 HERNIA 7 0.0004
636 DERMATITIS ATOPIC 19 0.0004
637 EOSINOPHIL COUNT INCREASED 3 0.0004
638 NEOPLASM MALIGNANT 24 0.0004
639 HUNGER 5 0.0004
640 ARTHRALGIA 149 0.0004
641 CRYING 13 0.0004
642 NEUROPATHY PERIPHERAL 34 0.0004
643 EYE PRURITUS 12 0.0004
644 PRODUCTIVE COUGH 17 0.0004
645 MICTURITION URGENCY 4 0.0003
646 CHOLECYSTECTOMY 4 0.0003
647 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
648 SYNCOPE 35 0.0003
649 CHILLS 41 0.0003
650 METASTASES TO LUNG 4 0.0003
651 SKIN SWELLING 3 0.0003
652 HYPERTHYROIDISM 5 0.0003
653 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
654 ORTHOSTATIC HYPOTENSION 6 0.0003
655 HYPOTHYROIDISM 11 0.0003
656 HYPOKINESIA 5 0.0003
657 DEAFNESS 9 0.0003
658 NAIL DISORDER 3 0.0003
659 OFF LABEL USE 300 0.0003
660 FALL 114 0.0003
661 GROIN PAIN 3 0.0003
662 GRIP STRENGTH DECREASED 3 0.0003
663 OSTEOPOROSIS 14 0.0003
664 INFLUENZA LIKE ILLNESS 28 0.0003
665 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
666 SWELLING FACE 22 0.0003
667 ARRHYTHMIA 16 0.0003
668 PERIPHERAL SWELLING 52 0.0003
669 WEIGHT DECREASED 94 0.0003
670 ISCHAEMIC STROKE 6 0.0003
671 PRODUCT PRESCRIBING ERROR 8 0.0003
672 BACK PAIN 78 0.0003
673 GASTROINTESTINAL INFECTION 3 0.0003
674 THYROID CANCER 4 0.0003
675 MOUTH ULCERATION 7 0.0003
676 INFLUENZA 37 0.0003
677 LEUKOCYTOSIS 6 0.0003
678 TOOTHACHE 6 0.0003
679 LACRIMATION INCREASED 10 0.0003
680 LIP SWELLING 11 0.0003
681 RESTLESS LEGS SYNDROME 6 0.0003
682 LUNG DISORDER 16 0.0003
683 WEIGHT INCREASED 73 0.0003
684 NASOPHARYNGITIS 60 0.0003
685 OVARIAN CANCER 3 0.0003
686 ANGER 11 0.0003
687 DEVICE RELATED INFECTION 5 0.0003
688 EMOTIONAL DISORDER 10 0.0003
689 SWELLING 30 0.0003
690 INTESTINAL OBSTRUCTION 12 0.0003
691 DERMATITIS ALLERGIC 4 0.0003
692 SPUTUM DISCOLOURED 3 0.0003
693 GLOSSODYNIA 7 0.0003
694 BLOOD GLUCOSE DECREASED 15 0.0003
695 RASH PAPULAR 7 0.0003
696 AFFECT LABILITY 3 0.0003
697 MOVEMENT DISORDER 10 0.0003
698 ATELECTASIS 3 0.0003
699 ANAPHYLACTIC SHOCK 8 0.0003
700 INFLAMMATION 16 0.0003
701 DECREASED APPETITE 72 0.0003
702 HEPATIC ENZYME INCREASED 21 0.0003
703 HAEMORRHOIDS 6 0.0003
704 AMNESIA 20 0.0003
705 HYPERSENSITIVITY 57 0.0003
706 INFLAMMATORY BOWEL DISEASE 3 0.0003
707 ABDOMINAL PAIN 71 0.0003
708 HALLUCINATION 23 0.0003
709 THERAPY CHANGE 3 0.0003
710 MANIA 5 0.0003
711 IMMUNE SYSTEM DISORDER 4 0.0003
712 SARS-COV-2 TEST POSITIVE 4 0.0003
713 RASH 132 0.0003
714 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
715 BLADDER DISORDER 3 0.0003
716 INABILITY TO AFFORD MEDICATION 3 0.0003
717 INFUSION RELATED REACTION 20 0.0003
718 UNDERDOSE 22 0.0003
719 ABORTION SPONTANEOUS 12 0.0003
720 MUSCULAR WEAKNESS 34 0.0003
721 PSORIATIC ARTHROPATHY 12 0.0003
722 TOOTH ABSCESS 3 0.0003
723 EPILEPSY 9 0.0003
724 NEUTROPHIL COUNT INCREASED 3 0.0003
725 THERAPY CESSATION 15 0.0003
726 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
727 LOCALISED INFECTION 7 0.0003
728 DIVERTICULITIS 8 0.0003
729 NERVOUS SYSTEM DISORDER 9 0.0003
730 TENDERNESS 3 0.0003
731 PETECHIAE 3 0.0003
732 MUSCULOSKELETAL STIFFNESS 25 0.0003
733 PAIN IN EXTREMITY 84 0.0003
734 MALAISE 125 0.0003
735 HALLUCINATION, VISUAL 6 0.0003
736 INCONTINENCE 3 0.0003
737 GAIT DISTURBANCE 54 0.0003
738 BODY HEIGHT DECREASED 3 0.0003
739 NIGHT SWEATS 9 0.0003
740 MOBILITY DECREASED 20 0.0003
741 CELLULITIS 14 0.0003
742 DISORIENTATION 11 0.0003
743 DRY SKIN 37 0.0003
744 BACK INJURY 3 0.0003
745 DIARRHOEA 178 0.0003
746 PRODUCT DISPENSING ERROR 6 0.0003
747 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
748 RESTLESSNESS 10 0.0003
749 RHEUMATOID ARTHRITIS 31 0.0003
750 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
751 SKIN EXFOLIATION 23 0.0003
752 DYSURIA 10 0.0003
753 CARDIOMYOPATHY 4 0.0003
754 TACHYCARDIA 24 0.0003
755 SKIN HAEMORRHAGE 4 0.0003
756 NERVE INJURY 3 0.0003
757 DYSGEUSIA 20 0.0003
758 DYSPNOEA 152 0.0003
759 ORAL PAIN 6 0.0003
760 TYPE 2 DIABETES MELLITUS 9 0.0003
761 BLOOD CALCIUM DECREASED 3 0.0003
762 CONDITION AGGRAVATED 81 0.0003
763 CHROMATURIA 6 0.0003
764 HEART RATE IRREGULAR 6 0.0003
765 DYSPNOEA EXERTIONAL 10 0.0003
766 DRUG INTERACTION 42 0.0003
767 SCAB 3 0.0003
768 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
769 INFECTION 38 0.0003
770 SKIN DISCOLOURATION 12 0.0003
771 PULMONARY FIBROSIS 5 0.0003
772 DELIRIUM 9 0.0003
773 TENDONITIS 4 0.0003
774 RASH PRURITIC 14 0.0003
775 PRODUCT USE IN UNAPPROVED INDICATION 64 0.0003
776 ERYTHEMA 53 0.0003
777 RENAL DISORDER 12 0.0003
778 PALLOR 7 0.0003
779 BLOOD PRESSURE DECREASED 17 0.0003
780 PRODUCT USE ISSUE 48 0.0003
781 SKIN LESION 7 0.0003
782 MENTAL DISORDER 11 0.0003
783 PNEUMOTHORAX 4 0.0003
784 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
785 HYPERLIPIDAEMIA 3 0.0003
786 SEPSIS 28 0.0003
787 UPPER LIMB FRACTURE 5 0.0003
788 PRESCRIBED UNDERDOSE 5 0.0003
789 CONTUSION 24 0.0002
790 BLISTER 14 0.0002
791 THROMBOSIS 20 0.0002
792 ADRENAL INSUFFICIENCY 3 0.0002
793 CEREBRAL INFARCTION 6 0.0002
794 INJURY ASSOCIATED WITH DEVICE 5 0.0002
795 CHOLELITHIASIS 8 0.0002
796 HERPES ZOSTER 14 0.0002
797 GENERALISED OEDEMA 3 0.0002
798 ILEUS 3 0.0002
799 EPISTAXIS 18 0.0002
800 PULMONARY HYPERTENSION 5 0.0002
801 INTENTIONAL PRODUCT MISUSE 21 0.0002
802 COLITIS 9 0.0002
803 PSYCHOTIC DISORDER 7 0.0002
804 PRODUCT COMPLAINT 6 0.0002
805 ASTHENIA 89 0.0002
806 INCORRECT DOSE ADMINISTERED 54 0.0002
807 CARDIOVASCULAR DISORDER 6 0.0002
808 INJECTION SITE IRRITATION 3 0.0002
809 RETCHING 5 0.0002
810 HYPOTENSION 47 0.0002
811 GASTRIC DISORDER 8 0.0002
812 PARANOIA 4 0.0002
813 OCULAR HYPERAEMIA 11 0.0002
814 EXPOSURE VIA SKIN CONTACT 6 0.0002
815 INJECTION SITE INDURATION 3 0.0002
816 VAGINAL HAEMORRHAGE 10 0.0002
817 PLATELET COUNT INCREASED 3 0.0002
818 RASH ERYTHEMATOUS 11 0.0002
819 PRODUCT PRESCRIBING ISSUE 5 0.0002
820 CONFUSIONAL STATE 37 0.0002
821 GALLBLADDER DISORDER 4 0.0002
822 MYALGIA 38 0.0002
823 CEREBRAL HAEMORRHAGE 8 0.0002
824 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
825 HOSPITALISATION 34 0.0002
826 COMPLICATION OF DEVICE REMOVAL 4 0.0002
827 OEDEMA 12 0.0002
828 CYSTITIS 7 0.0002
829 GINGIVAL BLEEDING 3 0.0002
830 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
831 SKIN IRRITATION 10 0.0002
832 HAEMATOCHEZIA 12 0.0002
833 RESPIRATORY DISTRESS 6 0.0002
834 PNEUMONIA 70 0.0002
835 IRRITABILITY 13 0.0002
836 WOUND 6 0.0002
837 SKIN REACTION 3 0.0002
838 EXPIRED PRODUCT ADMINISTERED 7 0.0002
839 DIABETES MELLITUS 16 0.0002
840 INCREASED APPETITE 4 0.0002
841 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
842 LOWER LIMB FRACTURE 4 0.0002
843 DEVICE DISLOCATION 9 0.0002
844 SEPTIC SHOCK 9 0.0002
845 ERUCTATION 4 0.0002
846 PRESCRIBED OVERDOSE 4 0.0002
847 NEEDLE ISSUE 6 0.0002
848 GASTROENTERITIS 3 0.0002
849 AGITATION 15 0.0002
850 CARDIAC DISORDER 19 0.0002
851 URINARY INCONTINENCE 6 0.0002
852 HOT FLUSH 15 0.0002
853 STOMATITIS 12 0.0002
854 OSTEOPENIA 3 0.0002
855 DYSKINESIA 8 0.0002
856 ADVERSE EVENT 18 0.0002
857 ATRIAL FIBRILLATION 19 0.0002
858 LYMPHOMA 3 0.0002
859 FLATULENCE 11 0.0002
860 MUSCULOSKELETAL CHEST PAIN 3 0.0002
861 UNRESPONSIVE TO STIMULI 5 0.0002
862 SKIN ULCER 5 0.0002
863 C-REACTIVE PROTEIN INCREASED 7 0.0002
864 BASAL CELL CARCINOMA 3 0.0002
865 ACCIDENTAL OVERDOSE 7 0.0002
866 JOINT SWELLING 23 0.0002
867 HALLUCINATION, AUDITORY 3 0.0002
868 FEAR 5 0.0002
869 FAECES DISCOLOURED 4 0.0002
870 CHRONIC KIDNEY DISEASE 14 0.0002
871 IMPAIRED HEALING 6 0.0002
872 PYREXIA 63 0.0002
873 URINARY RETENTION 6 0.0002
874 COLITIS ULCERATIVE 8 0.0002
875 ANAEMIA 34 0.0002
876 TARDIVE DYSKINESIA 5 0.0002
877 PSORIASIS 23 0.0002
878 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
879 ANGINA PECTORIS 5 0.0002
880 DEVICE DEFECTIVE 3 0.0002
881 DEVICE USE ERROR 6 0.0002
882 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
883 NERVOUSNESS 9 0.0002
884 MYOCARDIAL INFARCTION 30 0.0002
885 SYRINGE ISSUE 3 0.0002
886 PULMONARY EMBOLISM 16 0.0002
887 DISEASE RECURRENCE 8 0.0002
888 POLLAKIURIA 7 0.0002
889 RESPIRATORY DISORDER 5 0.0002
890 BLOOD PRESSURE FLUCTUATION 4 0.0002
891 OSTEOMYELITIS 3 0.0002
892 OSTEOARTHRITIS 7 0.0002
893 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
894 BLOOD GLUCOSE ABNORMAL 3 0.0002
895 AGEUSIA 4 0.0002
896 HEPATIC CIRRHOSIS 3 0.0002
897 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
898 GASTRIC ULCER 3 0.0002
899 FLUID RETENTION 8 0.0002
900 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
901 HYPOPHAGIA 4 0.0002
902 PRODUCT SUBSTITUTION ISSUE 9 0.0002
903 SEROTONIN SYNDROME 3 0.0002
904 DRUG RESISTANCE 4 0.0002
905 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
906 HAEMORRHAGE 16 0.0002
907 HAEMATOCRIT DECREASED 3 0.0002
908 BRADYCARDIA 8 0.0002
909 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
910 SKIN DISORDER 5 0.0001
911 FULL BLOOD COUNT DECREASED 3 0.0001
912 SUICIDE ATTEMPT 9 0.0001
913 FREQUENT BOWEL MOVEMENTS 4 0.0001
914 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
915 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
916 MENTAL STATUS CHANGES 4 0.0001
917 DERMATITIS 3 0.0001
918 DEMENTIA 4 0.0001
919 RASH MACULAR 5 0.0001
920 EMOTIONAL DISTRESS 17 0.0001
921 SKIN BURNING SENSATION 10 0.0001
922 BREAST CANCER 13 0.0001
923 BLOOD CREATININE INCREASED 9 0.0001
924 HYPERGLYCAEMIA 5 0.0001
925 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
926 ACUTE MYOCARDIAL INFARCTION 4 0.0001
927 ANGIOEDEMA 6 0.0001
928 COMPLETED SUICIDE 11 0.0001
929 OEDEMA PERIPHERAL 16 0.0001
930 HYPOKALAEMIA 6 0.0001
931 EXPOSURE DURING PREGNANCY 8 0.0001
932 TREATMENT NONCOMPLIANCE 7 0.0001
933 DIABETIC KETOACIDOSIS 3 0.0001
934 OXYGEN SATURATION DECREASED 7 0.0001
935 HIP FRACTURE 4 0.0001
936 DEVICE BREAKAGE 5 0.0001
937 DEEP VEIN THROMBOSIS 8 0.0001
938 LUNG NEOPLASM MALIGNANT 5 0.0001
939 STAPHYLOCOCCAL INFECTION 4 0.0001
940 WITHDRAWAL SYNDROME 5 0.0001
941 HAEMATEMESIS 3 0.0001
942 HAEMATURIA 4 0.0001
943 HYPOACUSIS 5 0.0001
944 HAEMATOMA 3 0.0001
945 ANHEDONIA 3 0.0001
946 DEVICE MALFUNCTION 8 0.0001
947 PRODUCT QUALITY ISSUE 15 0.0001
948 TREATMENT FAILURE 9 0.0001
949 HAEMOPTYSIS 3 0.0001
950 RENAL IMPAIRMENT 9 0.0001
951 BLOOD GLUCOSE INCREASED 20 0.0001
952 RED BLOOD CELL COUNT DECREASED 3 0.0001
953 NO ADVERSE EVENT 19 0.0001
954 PLATELET COUNT DECREASED 11 0.0001
955 LIVER FUNCTION TEST ABNORMAL 3 0.0001
956 LABORATORY TEST ABNORMAL 3 0.0001
957 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
958 ABNORMAL BEHAVIOUR 4 0.0001
959 INJURY 7 0.0001
960 CORONARY ARTERY DISEASE 3 0.0001
961 ILL-DEFINED DISORDER 6 0.0001
962 EXTRA DOSE ADMINISTERED 4 0.0001
963 MUSCULOSKELETAL PAIN 5 0.0001
964 PANCREATITIS 5 0.0001
965 ACNE 7 0.0001
966 DEVICE LEAKAGE 4 0.0001
967 DEATH 78 0.0001
968 LIVER DISORDER 4 0.0001
969 HYPOXIA 3 0.0001
970 PLEURAL EFFUSION 5 0.0001
971 HAEMOGLOBIN DECREASED 8 0.0001
972 RECTAL HAEMORRHAGE 3 0.0001
973 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
974 PULMONARY OEDEMA 3 0.0001
975 DEVICE ISSUE 6 0.0001
976 INTERSTITIAL LUNG DISEASE 3 0.0001
977 AGGRESSION 3 0.0001
978 ARTHROPATHY 3 0.0001
979 ACUTE KIDNEY INJURY 8 0.0001
980 OVERDOSE 11 0.0001
981 CARDIAC FAILURE CONGESTIVE 4 0.0000
982 CARDIAC ARREST 4 0.0000
983 DEVICE EXPULSION 3 0.0000
984 DISEASE PROGRESSION 5 0.0000
985 RENAL FAILURE 5 0.0000
986 CARDIAC FAILURE 3 0.0000
987 PROSTATE CANCER 3 0.0000
988 DRUG WITHDRAWAL SYNDROME 3 0.0000
989 TOXICITY TO VARIOUS AGENTS 4 0.0000